Clinical Trial Update: Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating allogeneic mesenchymal stem cells plus physical therapy for multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Jordan | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED